Patients who received heart transplants from hepatitis C virus-positive vs -negative donors were found to have comparable survival at 1 year and patients who developed transplant-related hepatitis C responded well to treatment.
Adult heart transplants from hepatitis C virus-positive donors appear safe, with no increased risk for adverse effects on one-year survival.
Viral hepatitis causing concomitant acute pancreatitis is a rare entity and outcomes vary depending on the type of hepatitis virus.
Clinician adherence to screening protocols for patients with hepatitis B (HBV), as well as to treatment guidelines for those with hepatitis C virus (HCV) is suboptimal.
Hepatitis viruses are associated with a higher risk for psychiatric conditions in both adults and children.
Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide fumarate (TAF) is safe and effective in patients with chronic hepatitis B (HBV) and was linked to improvements in bone, renal, and kidney function.
Two studies on hepatitis A and hepatitis B vaccination highlight opportunities to improve coverage of ≥2 doses of hepatitis A vaccine in children and hepatitis B vaccine series completion in adults.
Hepatitis E seropositivity is higher in older adults and may represent an increased exposure risk over time; in contrast, the opioid crisis has caused a demographic shift in hepatitis C infection, which is now a predominately millennial disease.
The last four reported hepatitis A outbreaks during 1995 to 2009 were due to individual water systems
The FDA is warning healthcare professionals that cases of liver decompensation, including liver failure and death, have been linked to certain hepatitis C drugs.
